Enhancing Digitally Delivered Diabetes Education With Real-Time CGM

Recruiting N/A Interventional Study
Diabetes Type 2
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Any
Study type
Interventional
Purpose
Supportive Care
Participants needed
140 (estimated)
Sponsor
Scripps Whittier Diabetes Institute · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial

The current research study will add continuous glucose monitoring devices to the evidence-based text messaging diabetes education program for patients with type 2 diabetes for 6 months. Results on the effectiveness of this intervention will be compared for non-insulin using patients.

Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Diagnosed with type 2 diabetes * Are not currently using a CGM * Are not using insulin therapies * Speak English, Spanish or Arabic * Have A1c between 7.5% and 12.0% in last 90 days * Have a cellphone that can receive/send text messages and counts steps Exclusion Criteria: *…
Contacts

Kallie Brown, PhD

858-258-3555

brown.kallie@scrippshealth.org

CONTACT

Athena Philis-Tsimikas, MD

877-944-8843

philis-Tsimikas.athena@scrippshealth.org

CONTACT